000 00865 a2200229 4500
005 20250516113707.0
264 0 _c20121119
008 201211s 0 0 eng d
022 _a1471-1893
024 7 _a10.1136/jfprhc-2012-100428
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSparrow, Margaret
245 0 0 _aLicensing of mifepristone in New Zealand and Australia.
_h[electronic resource]
260 _bThe journal of family planning and reproductive health care
_cOct 2012
300 _a271 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCandida albicans
_xmetabolism
650 0 4 _aHumans
650 0 4 _aSkin
_xmetabolism
773 0 _tThe journal of family planning and reproductive health care
_gvol. 38
_gno. 4
_gp. 271
856 4 0 _uhttps://doi.org/10.1136/jfprhc-2012-100428
_zAvailable from publisher's website
999 _c22150480
_d22150480